Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AAI101 SAD/MAD and DDI study
NCT03685084Phase 1Completed
- Sponsor
- Allecra Therapeutics
- Start
- Oct 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of enmetazobactam in urinary tract infection (UTI) and acute pyelonephritis (4 arms), sponsored by Allecra Therapeutics. Primary endpoint: Number of Subjects With at Least one Adverse Event. Started Oct 2013; status: completed.
02
Drugs
enmetazobactam
03
Conditions
urinary tract infection (UTI)acute pyelonephritis
Beyond the preview
Go deeper on NCT03685084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03685084.